Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 124

1.

Bacteria-to-Human Protein Networks Reveal Origins of Endogenous DNA Damage.

Xia J, Chiu LY, Nehring RB, Bravo Núñez MA, Mei Q, Perez M, Zhai Y, Fitzgerald DM, Pribis JP, Wang Y, Hu CW, Powell RT, LaBonte SA, Jalali A, Matadamas Guzmán ML, Lentzsch AM, Szafran AT, Joshi MC, Richters M, Gibson JL, Frisch RL, Hastings PJ, Bates D, Queitsch C, Hilsenbeck SG, Coarfa C, Hu JC, Siegele DA, Scott KL, Liang H, Mancini MA, Herman C, Miller KM, Rosenberg SM.

Cell. 2019 Jan 10;176(1-2):127-143.e24. doi: 10.1016/j.cell.2018.12.008.

PMID:
30633903
2.

Strategic Storytelling: An Exploration of the Professional Practices of Mental Health Peer Providers.

Mancini MA.

Qual Health Res. 2019 Jan 7:1049732318821689. doi: 10.1177/1049732318821689. [Epub ahead of print]

PMID:
30616464
3.

Bexarotene - a novel modulator of AURKA and the primary cilium in VHL-deficient cells.

Chowdhury P, Powell RT, Stephan C, Uray IP, Talley T, Karki M, Tripathi DN, Park YS, Mancini MA, Davies P, Dere R.

J Cell Sci. 2018 Dec 14;131(24). pii: jcs219923. doi: 10.1242/jcs.219923.

4.

CARM1 methylates MED12 to regulate its RNA-binding ability.

Cheng D, Vemulapalli V, Lu Y, Shen J, Aoyagi S, Fry CJ, Yang Y, Foulds CE, Stossi F, Treviño LS, Mancini MA, O'Malley BW, Walker CL, Boyer TG, Bedford MT.

Life Sci Alliance. 2018 Sep 19;1(5):e201800117. doi: 10.26508/lsa.201800117. eCollection 2018 Oct.

5.

Steroid Receptor Coactivator-2 Controls the Pentose Phosphate Pathway through RPIA in Human Endometrial Cancer Cells.

Szwarc MM, Kommagani R, Putluri V, Dubrulle J, Stossi F, Mancini MA, Coarfa C, Lanz RB, Putluri N, DeMayo FJ, Lydon JP, O'Malley BW.

Sci Rep. 2018 Sep 3;8(1):13134. doi: 10.1038/s41598-018-31372-y.

6.

First molecular data for Lernaea cyprinacea (Copepoda: Cyclopoida) infesting Odontesthes bonariensis, a commercially important freshwater fish in Argentina.

Soares IA, Salinas V, Ponti OD, Mancini MA, Luque JL.

Rev Bras Parasitol Vet. 2018 Jan-Mar;27(1):106-109. doi: 10.1590/S1984-29612018005. Epub 2018 Feb 19.

7.

Characterizing properties of non-estrogenic substituted bisphenol analogs using high throughput microscopy and image analysis.

Szafran AT, Stossi F, Mancini MG, Walker CL, Mancini MA.

PLoS One. 2017 Jul 13;12(7):e0180141. doi: 10.1371/journal.pone.0180141. eCollection 2017.

8.

An Exploration of Factors that Effect the Implementation of Peer Support Services in Community Mental Health Settings.

Mancini MA.

Community Ment Health J. 2018 Feb;54(2):127-137. doi: 10.1007/s10597-017-0145-4. Epub 2017 May 2.

PMID:
28466237
9.

Bone-in-culture array as a platform to model early-stage bone metastases and discover anti-metastasis therapies.

Wang H, Tian L, Goldstein A, Liu J, Lo HC, Sheng K, Welte T, Wong STC, Gugala Z, Stossi F, Zong C, Li Z, Mancini MA, Zhang XH.

Nat Commun. 2017 Apr 21;8:15045. doi: 10.1038/ncomms15045.

10.

Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming.

Tian L, Goldstein A, Wang H, Ching Lo H, Sun Kim I, Welte T, Sheng K, Dobrolecki LE, Zhang X, Putluri N, Phung TL, Mani SA, Stossi F, Sreekumar A, Mancini MA, Decker WK, Zong C, Lewis MT, Zhang XH.

Nature. 2017 Apr 13;544(7649):250-254. doi: 10.1038/nature21724. Epub 2017 Apr 3.

11.

Primary Human Placental Trophoblasts are Permissive for Zika Virus (ZIKV) Replication.

Aagaard KM, Lahon A, Suter MA, Arya RP, Seferovic MD, Vogt MB, Hu M, Stossi F, Mancini MA, Harris RA, Kahr M, Eppes C, Rac M, Belfort MA, Park CS, Lacorazza D, Rico-Hesse R.

Sci Rep. 2017 Jan 27;7:41389. doi: 10.1038/srep41389.

12.

High-Content Screening Identifies Src Family Kinases as Potential Regulators of AR-V7 Expression and Androgen-Independent Cell Growth.

Szafran AT, Stephan C, Bolt M, Mancini MG, Marcelli M, Mancini MA.

Prostate. 2017 Jan;77(1):82-93. doi: 10.1002/pros.23251. Epub 2016 Oct 4.

13.

The Germ Cell Gene TDRD1 as an ERG Target Gene and a Novel Prostate Cancer Biomarker.

Xiao L, Lanz RB, Frolov A, Castro PD, Zhang Z, Dong B, Xue W, Jung SY, Lydon JP, Edwards DP, Mancini MA, Feng Q, Ittmann MM, He B.

Prostate. 2016 Oct;76(14):1271-84. doi: 10.1002/pros.23213. Epub 2016 Jun 8.

PMID:
27272765
14.

CUDC-101, a Novel Inhibitor of Full-Length Androgen Receptor (flAR) and Androgen Receptor Variant 7 (AR-V7) Activity: Mechanism of Action and In Vivo Efficacy.

Sun H, Mediwala SN, Szafran AT, Mancini MA, Marcelli M.

Horm Cancer. 2016 Jun;7(3):196-210. doi: 10.1007/s12672-016-0257-2. Epub 2016 Mar 8.

15.

High throughput microscopy identifies bisphenol AP, a bisphenol A analog, as a novel AR down-regulator.

Stossi F, Dandekar RD, Bolt MJ, Newberg JY, Mancini MG, Kaushik AK, Putluri V, Sreekumar A, Mancini MA.

Oncotarget. 2016 Mar 29;7(13):16962-74. doi: 10.18632/oncotarget.7655.

16.

Differential Regulation of Progesterone Receptor-Mediated Transcription by CDK2 and DNA-PK.

Treviño LS, Bolt MJ, Grimm SL, Edwards DP, Mancini MA, Weigel NL.

Mol Endocrinol. 2016 Feb;30(2):158-72. doi: 10.1210/me.2015-1144. Epub 2015 Dec 11.

17.

Use of HCA in subproteome-immunization and screening of hybridoma supernatants to define distinct antibody binding patterns.

Szafran AT, Mancini MG, Nickerson JA, Edwards DP, Mancini MA.

Methods. 2016 Mar 1;96:75-84. doi: 10.1016/j.ymeth.2015.10.021. Epub 2015 Oct 30.

18.

Characterization of a Steroid Receptor Coactivator Small Molecule Stimulator that Overstimulates Cancer Cells and Leads to Cell Stress and Death.

Wang L, Yu Y, Chow DC, Yan F, Hsu CC, Stossi F, Mancini MA, Palzkill T, Liao L, Zhou S, Xu J, Lonard DM, O'Malley BW.

Cancer Cell. 2015 Aug 10;28(2):240-52. doi: 10.1016/j.ccell.2015.07.005.

19.

Drug use and service utilization among Hispanics in the United States.

Mancini MA, Salas-Wright CP, Vaughn MG.

Soc Psychiatry Psychiatr Epidemiol. 2015 Nov;50(11):1679-89. doi: 10.1007/s00127-015-1111-5. Epub 2015 Aug 11.

PMID:
26260951
20.

Ubc9 Impairs Activation of the Brown Fat Energy Metabolism Program in Human White Adipocytes.

Hartig SM, Bader DA, Abadie KV, Motamed M, Hamilton MP, Long W, York B, Mueller M, Wagner M, Trauner M, Chan L, Bajaj M, Moore DD, Mancini MA, McGuire SE.

Mol Endocrinol. 2015 Sep;29(9):1320-33. doi: 10.1210/me.2015-1084. Epub 2015 Jul 20.

21.
22.

The epidermal growth factor receptor critically regulates endometrial function during early pregnancy.

Large MJ, Wetendorf M, Lanz RB, Hartig SM, Creighton CJ, Mancini MA, Kovanci E, Lee KF, Threadgill DW, Lydon JP, Jeong JW, DeMayo FJ.

PLoS Genet. 2014 Jun 19;10(6):e1004451. doi: 10.1371/journal.pgen.1004451. eCollection 2014 Jun.

23.

Defining estrogenic mechanisms of bisphenol A analogs through high throughput microscopy-based contextual assays.

Stossi F, Bolt MJ, Ashcroft FJ, Lamerdin JE, Melnick JS, Powell RT, Dandekar RD, Mancini MG, Walker CL, Westwick JK, Mancini MA.

Chem Biol. 2014 Jun 19;21(6):743-53. doi: 10.1016/j.chembiol.2014.03.013. Epub 2014 May 22.

24.

Unraveling the regulatory connections between two controllers of breast cancer cell fate.

Lee J, Tiwari A, Shum V, Mills GB, Mancini MA, Igoshin OA, Balázsi G.

Nucleic Acids Res. 2014 Jun;42(11):6839-49. doi: 10.1093/nar/gku360. Epub 2014 May 3.

25.

Drug-repositioning screening identified piperlongumine as a direct STAT3 inhibitor with potent activity against breast cancer.

Bharadwaj U, Eckols TK, Kolosov M, Kasembeli MM, Adam A, Torres D, Zhang X, Dobrolecki LE, Wei W, Lewis MT, Dave B, Chang JC, Landis MD, Creighton CJ, Mancini MA, Tweardy DJ.

Oncogene. 2015 Mar 12;34(11):1341-53. doi: 10.1038/onc.2014.72. Epub 2014 Mar 31.

26.

The myImageAnalysis project: a web-based application for high-content screening.

Szafran AT, Mancini MA.

Assay Drug Dev Technol. 2014 Jan-Feb;12(1):87-99. doi: 10.1089/adt.2013.532.

27.

Systems level-based RNAi screening by high content analysis identifies UBR5 as a regulator of estrogen receptor-α protein levels and activity.

Bolt MJ, Stossi F, Callison AM, Mancini MG, Dandekar R, Mancini MA.

Oncogene. 2015 Jan 8;34(2):154-64. doi: 10.1038/onc.2013.550. Epub 2014 Jan 20.

28.

Learning and change in a community mental health setting.

Mancini MA, Miner CS.

J Evid Based Soc Work. 2013 Oct;10(5):494-504. doi: 10.1080/15433714.2012.760944.

PMID:
24066638
29.

Statewide implementation of recovery support groups for people with serious mental illness: a multidimensional evaluation.

Mancini MA, Linhorst DM, Menditto AA, Coleman J.

J Behav Health Serv Res. 2013 Oct;40(4):391-403. doi: 10.1007/s11414-013-9351-1.

PMID:
23812832
30.

Coactivators enable glucocorticoid receptor recruitment to fine-tune estrogen receptor transcriptional responses.

Bolt MJ, Stossi F, Newberg JY, Orjalo A, Johansson HE, Mancini MA.

Nucleic Acids Res. 2013 Apr;41(7):4036-48. doi: 10.1093/nar/gkt100. Epub 2013 Feb 26.

31.

Differential phosphorylation of perilipin 1A at the initiation of lipolysis revealed by novel monoclonal antibodies and high content analysis.

McDonough PM, Maciejewski-Lenoir D, Hartig SM, Hanna RA, Whittaker R, Heisel A, Nicoll JB, Buehrer BM, Christensen K, Mancini MG, Mancini MA, Edwards DP, Price JH.

PLoS One. 2013;8(2):e55511. doi: 10.1371/journal.pone.0055511. Epub 2013 Feb 6.

32.

Feed-forward inhibition of androgen receptor activity by glucocorticoid action in human adipocytes.

Hartig SM, He B, Newberg JY, Ochsner SA, Loose DS, Lanz RB, McKenna NJ, Buehrer BM, McGuire SE, Marcelli M, Mancini MA.

Chem Biol. 2012 Sep 21;19(9):1126-41. doi: 10.1016/j.chembiol.2012.07.020.

33.

Peptidylarginine deiminase 2-catalyzed histone H3 arginine 26 citrullination facilitates estrogen receptor α target gene activation.

Zhang X, Bolt M, Guertin MJ, Chen W, Zhang S, Cherrington BD, Slade DJ, Dreyton CJ, Subramanian V, Bicker KL, Thompson PR, Mancini MA, Lis JT, Coonrod SA.

Proc Natl Acad Sci U S A. 2012 Aug 14;109(33):13331-6. doi: 10.1073/pnas.1203280109. Epub 2012 Aug 1.

34.

The activity of the androgen receptor variant AR-V7 is regulated by FOXO1 in a PTEN-PI3K-AKT-dependent way.

Mediwala SN, Sun H, Szafran AT, Hartig SM, Sonpavde G, Hayes TG, Thiagarajan P, Mancini MA, Marcelli M.

Prostate. 2013 Feb 15;73(3):267-77. doi: 10.1002/pros.22566. Epub 2012 Jul 20.

35.

Numerical framework to model temporally resolved multi-stage dynamic systems.

Zakharov MN, Bhasin S, Szafran AT, Mancini MA, Jasuja R.

Comput Methods Programs Biomed. 2012 Nov;108(2):750-9. doi: 10.1016/j.cmpb.2012.04.010. Epub 2012 Jun 22.

PMID:
22727632
36.

Berardinelli-seip congenital lipodystrophy 2/seipin is a cell-autonomous regulator of lipolysis essential for adipocyte differentiation.

Chen W, Chang B, Saha P, Hartig SM, Li L, Reddy VT, Yang Y, Yechoor V, Mancini MA, Chan L.

Mol Cell Biol. 2012 Mar;32(6):1099-111. doi: 10.1128/MCB.06465-11. Epub 2012 Jan 23.

37.

A framework for image-based classification of mitotic cells in asynchronous populations.

Slattery SD, Newberg JY, Szafran AT, Hall RM, Brinkley BR, Mancini MA.

Assay Drug Dev Technol. 2012 Apr;10(2):161-78. doi: 10.1089/adt.2011.0397. Epub 2011 Nov 15.

38.

Cancer-preventive rexinoid modulates neutral lipid contents of mammary epithelial cells through a peroxisome proliferator-activated receptor γ-dependent mechanism.

Uray IP, Rodenberg JM, Bissonnette RP, Brown PH, Mancini MA.

Mol Pharmacol. 2012 Feb;81(2):228-38. doi: 10.1124/mol.111.072967. Epub 2011 Nov 3.

39.

Consumer and practitioner perceptions of the harm reduction approach in a community mental health setting.

Mancini MA, Wyrick-Waugh W.

Community Ment Health J. 2013 Feb;49(1):14-24. doi: 10.1007/s10597-011-9451-4. Epub 2011 Oct 19.

PMID:
22009266
40.

Automated microscopy and image analysis for androgen receptor function.

Hartig SM, Newberg JY, Bolt MJ, Szafran AT, Marcelli M, Mancini MA.

Methods Mol Biol. 2011;776:313-31. doi: 10.1007/978-1-61779-243-4_18.

41.

Androgen receptor mutations associated with androgen insensitivity syndrome: a high content analysis approach leading to personalized medicine.

Szafran AT, Sun H, Hartig S, Shen Y, Mediwala SN, Bell J, McPhaul MJ, Mancini MA, Marcelli M.

Adv Exp Med Biol. 2011;707:63-5. doi: 10.1007/978-1-4419-8002-1_15. No abstract available.

PMID:
21691957
42.

Efficacy and safety of bowel cleansing solutions for colonoscopy: a prospective observational study.

Allegretti A, Bargallò Carulla D, Bertelè A, Franzèc A, Kouroumalis EA, Mancini MA, Paspatis G, Reina-Serrano S.

Eur Rev Med Pharmacol Sci. 2010 Nov;14(11):979-85.

PMID:
21284347
43.

High content imaging-based assay to classify estrogen receptor-α ligands based on defined mechanistic outcomes.

Ashcroft FJ, Newberg JY, Jones ED, Mikic I, Mancini MA.

Gene. 2011 May 15;477(1-2):42-52. doi: 10.1016/j.gene.2011.01.009. Epub 2011 Jan 20.

44.

Homeostatic levels of SRC-2 and SRC-3 promote early human adipogenesis.

Hartig SM, He B, Long W, Buehrer BM, Mancini MA.

J Cell Biol. 2011 Jan 10;192(1):55-67. doi: 10.1083/jcb.201004026.

45.

Harm reduction in community mental health settings.

Mancini MA, Linhorst DM.

J Soc Work Disabil Rehabil. 2010;9(2):130-47. doi: 10.1080/1536710X.2010.493481.

PMID:
20730672
46.

Ligand-induced large-scale chromatin dynamics as a biosensor for the detection of estrogen receptor subtype selective ligands.

García-Becerra R, Berno V, Ordaz-Rosado D, Sharp ZD, Cooney AJ, Mancini MA, Larrea F.

Gene. 2010 Jun 15;458(1-2):37-44. doi: 10.1016/j.gene.2010.03.007. Epub 2010 Mar 24.

PMID:
20347019
47.

The hinge region of the human estrogen receptor determines functional synergy between AF-1 and AF-2 in the quantitative response to estradiol and tamoxifen.

Zwart W, de Leeuw R, Rondaij M, Neefjes J, Mancini MA, Michalides R.

J Cell Sci. 2010 Apr 15;123(Pt 8):1253-61. doi: 10.1242/jcs.061135. Epub 2010 Mar 23.

48.

SRC-3Delta4 mediates the interaction of EGFR with FAK to promote cell migration.

Long W, Yi P, Amazit L, LaMarca HL, Ashcroft F, Kumar R, Mancini MA, Tsai SY, Tsai MJ, O'Malley BW.

Mol Cell. 2010 Feb 12;37(3):321-32. doi: 10.1016/j.molcel.2010.01.004.

49.

Discovery and mechanistic characterization of a novel selective nuclear androgen receptor exporter for the treatment of prostate cancer.

Narayanan R, Yepuru M, Szafran AT, Szwarc M, Bohl CE, Young NL, Miller DD, Mancini MA, Dalton JT.

Cancer Res. 2010 Jan 15;70(2):842-51. doi: 10.1158/0008-5472.CAN-09-3206. Epub 2010 Jan 12.

50.

Androgen receptor mutations associated with androgen insensitivity syndrome: a high content analysis approach leading to personalized medicine.

Szafran AT, Hartig S, Sun H, Uray IP, Szwarc M, Shen Y, Mediwala SN, Bell J, McPhaul MJ, Mancini MA, Marcelli M.

PLoS One. 2009 Dec 9;4(12):e8179. doi: 10.1371/journal.pone.0008179.

Supplemental Content

Loading ...
Support Center